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Abstract: Cancer is the main cause of mortality at the developed countries and is the second 
cause of mortality at the developing countries and breast cancer is the most prevalent 
malignancy and the first cause of mortality among women of the world. At the US, 28% of 
new cancer cases and 15% of mortality caused by that in 2010 was caused by breast cancer. 
Moreover, breast cancer is the most common cancer among Iranian women, which includes 
24.4% of overall malignancies and causes 3.3% of mortalities per 1.000 people. The disease 
is most spread in Tehran and including 25.5% of all cancers. According to the mentioned, 
the study has tried to assess the effect of nanotechnology in form of a review to diagnose 
and treat breast cancer. The method applied in this study is descriptive analytical method 
and library method has been used for data collection purpose. In the data collection method, 
45 articles relevant to structure of types of nanoparticles and their uses in diagnosis, 
imaging and medicine delivery systems and breast cancer treatment have been used. 
Although there are still some challenges and limitations to use nanoparticles in medication, 
it is hope that nanoparticles can make wonderful revolution not only in oncology, but also 
in medication in near future. The most underlying headlines of the present study include 
mineral nanoparticles, antibodies and tumor imaging methods. 
Keywords: magnetic nanoparticles, breast cancer, nanobody.  
1 Introduction  
The nanotechnology science has helped diagnosis and treatment 
of diseases by using nanoparticles and development of systematic 
drug delivery methods. Nanoparticles have high potential in field 
of diagnosis and treatment of diseases, especially cancer. Using 
these nanoparticles as factors increasing contrast in conventional 
imaging method of magnetic resonance and as nano-carriers in 
modern drug delivery systems have gained attention of scholars 
over the years. Systematic transfer of chemotherapy factors to 
cancer cells using magnetic nanoparticles under in vivo and in situ 
conditions has been studied and valuable results have been 
obtained. Moreover, the nanoparticles are applicable in treatment 
of cancer using heating method and transfer of nucleic acids, 
plasmids and siRNA to cells. Diagnosis of the disease in early 
stages can be underlying for improvement and treatment methods. 
recently, the treatment methods used to diagnose cancer are taken 
usually based on changes in cells and tissues and this can be also 
done by medical clinical examinations and using conventional 
imaging methods. However, scientists tend to diagnose cancer 
with appearance of the first molecular changes. Iron oxide 
nanoparticles are currently the only nanomaterials used in clinical 
medicine as the factor for contradiction in magnetic resonance 
imaging and as carrier in drug delivery. Experiments taken over 
the years on iron oxide nanoparticles show that the particles have 
no immediate toxic or long-term effect in vivo conditions; 
although presence of some nanoparticles, along with nano-
carriers, can enhance their effect and function on cancer cells. To 
this end, the nanoparticles can reinforce nano-carriers by means of 
different mechanisms such as increased oxidative stress and 
proper drug accumulation in the cell [1-2]. Annually, more than 
1.1million cases of breast cancer are being reported and more than 
410.000 people die because of breast cancer [2]. There are many 
treatment methods for breast cancer such as surgery, radiotherapy 
and hormone therapy, which have lots of complications and 
disadvantages. For example, tamoxifen used in chemotherapy for 
treatment of breast cancer can cause cancer in endometrial tissues. 
Therefore, it is required to make a system to deliver drug to tumor 
tissue with zero complications [1]. Using nanoparticles in food 
industry, electronics and medication is being developed. Preparing 
particles in nano size (smaller than 100nm) has increased their 
levels and has increased their reaction with organic and 
nonorganic molecules [3]. Using nanotechnology in medication  
refers to use very tiny articles (1-1000nm) in field of diagnosis and 
treatment of human cancers causing a new scientific branch in  
oncology under the title of nano-oncology [4, 5]. Nanoparticles 
have been developed for imaging, showing biomolecules and 
cancer biomarkers and systemizing drug carrying. Fixing  
chemotherapy drugs, especially in kind of enzyme in polymer 
nanoparticles, has led to increase their resistance to heat, pH, 
proteases and other destructive factors [6]. Semi-Conductor 
Fluorescent Nonocrystals such as quantum dots conjugated with 
antibodies can cause marking determining their exact amount in a 
small piece of breast tumor [7]. Other particles in nano scale such 
as nano-cantilerer and nano probes and coupled nanoparticles with 
specific ligands have been studied in field of cancer tumor imaging 
and determining environmental metastasis [8, 9]. Relevant studies 
have shown that nanoparticles conjugated with metal core and 
super magnetic force with biologic antibodies against ERBB2 
gene can simultaneously be useful in imaging and treatment of 
breast cancer [10]. Over the years, advancement of 
nanotechnology has caused use of nanoparticles in different fields 
of electronics, optic devices, industries, disease diagnosis, drug 
delivery, biosensors, imaging, and production of consumptive 
products such as sunscreens, cosmetics and sport instruments. The 
aim by this study is to investigate the studies in field of structure 
of types of nanoparticles and using them in diagnosis, imaging and 
drug delivery systems and to treat cancer. 
2 Methodology 
For purpose of data collection, databases such as Pubmed and 
Google Scholar were used. The researches and reviews using MeSH 
model included malignancy, cancer, neoplasm, nanotechnology, 
nanoparticles, aptamers, tumor imaging, magnetic nanoparticles, 
liposomes, biomarkers, interference small RNA, diagnosis and 
treatment methods of breast cancer using nanoparticles and 
nanobodies. 
2.1 Types of nanoparticles used in medication 
The nanoparticles used in medication field are classified in 2 main 
groups: particles containing organic molecules as the main structural 
substance and second group include metals and minerals as central 
core. Liposomes, dendrimers, carbon nanotubes (CNTs), emulsions, 
aptamers, solid lipid nanoparticles, nanobodies and other polymers 
have been recognized as organic particles [11-13]. 
2.2 Liposomes and dendrimers 
Liposomes can be used as chemotherapy drug carrier for different 
human tumors such as breast cancer [14] (figure 1). Dendrimers 
can be used as contrast factor in MRI and can be the assisting 
factor to clear pathologic procedures [15, 16].  
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 Figure 1: drug-carrying liposome [14]
2.3 Aptamers 
Aptamers are oligonucleotide (RNA or ssDNA) and peptides 
molecules attached to target molecule (small biomolecules, 
proteins and even cells) with high tendency and specificity and can 
be instruments to diagnose and treat diseases such as cancer [13]. 
DNA stability of aptamers is higher than RNA; although RNA 
aptamers have higher flexibility. 
Peptide aptamers have been made of a variable peptide loop 
attached in the end to a protein scaffold. The variable loop includes 
10-20 amino acids and protein scaffold incudes any kind of protein 
with high solubility. Moreover, aptamers can be used in drug 
carrying systems. The aptamers have been bonded to cell surface 
receptors and have trend to be dragged inside the cell. siRNAs can 
be used todat as new technique for treatment. Their function is 
induction of iRNA to regulate special gene expression. Safe, 
specific and efficient delivery of siRNAs inside the special cells is 
underlying in field of treatment and medication [17]. 
2.4 Nanobodies 
Sharks have antibodies without light-chain, and contain just 
heavy-chain and are called heavy chain antibodies (HCAbs). The 
antibodies lack CH1 domain; although they contain CH2 and CH3 
domains, which are highly similar to common antibodies. 
Therefore, Fb part bonded to antigen in conventional antibodies is 
limited to a variable domain in HCAb antibodies. As it was 
mentioned, it includes just heavy chain called HHV. As its size is 
in limit of nano scale (2-5nm in diameter and 4nm in height), they 
are called nanobodies and can be used abundantly in 
nanotechnology. Nowadays, monoclonal nanobodies can be 
produced in bacteria and they are more resistant than conventional 
antibodies because of their small size, have high solubility and 
have high specificity to antigen. Therefore, they have high 
potential to diagnose and treat cancer [2]. 
In the studies conducted by Katrien Van Impe et al on rats, using 
nanobodies could decrease the metastasis of cancer cells of breast 
glands in these rats [18]. In 20-30% of breast cancers, it has been 
observed that the expression and activity of 2 surface antigens of 
HER1 and HER2 was increased [19]. Through making specific 
nanobodies of the two surface receptors, cancer can be diagnosed 
and treated. 
3. Findings 
3.1 Magnetic nanoparticles, diagnosis and treatment 
The issue of systematic drug carrying is mostly considered for 
cancer treatment, since the main challenge in treatment of cancer is 
targeting and destroying cancer cells, so that it can have lowest effect 
on healthy cells. One of the main purposes of nanotechnology is  
carrying drugs on carriers (nanoparticles), sending, and leaving them 
in target cells, which can be called as systematic drug delivery. 
Using magnetic nanoparticles and creating a magnetic field, drug 
can be delivered to desired tissue intelligently and cause healing in 
tissue without damaging other tissues [20, 21]. In order to use 
magnetic nanoparticles in medical uses, those showing super 
paramagnetic phenomenon in ambient temperature are preferred, 
since the magnetic property of these particles can be lost in absence 
of magnetic field and cannot remain. Moreover, existence of 
magnetic remains in these materials can lead to their coagulation and 
this can cause blockage of blood in vessels. Therefore, for such uses, 
using compounds with super paramagnetic property is essential [21-
25]. In general, super paramagnetic property is a kind of magnetic 
property observed in ferromagnetic small nanoparticles. In 
sufficiently tiny particles, magnetism can be changed randomly 
under the effect of temperature. In absence of external magnetic 
field, when the time sued to measure magnetism of nanoparticles is 
significantly longer than rest time, average magnetism of the 
particles becomes zero and it could be mentioned that particles are 
under super paramagnetic conditions (figure 2). 
Figure 2: behavior of super paramagnetic particles 
applicable in biomedical fields, especially accumulation 
of nanoparticles in place of tumor [9]  
Underlying for medical diagnosis uses such as nanoparticles to 
enhance the contrast of magnetic resonance images [33]. Underlying 
points about nanoparticles used in medical cases are that the size and 
distribution of size of particles should be thin. Magnetic 
nanoparticles should have desirable form, size and surface properties 
to shoot the tumors. For example, in biologic uses and medical 
diagnosis, magnetic nanoparticles can be used without cell toxicity 
and stable in water and natural pH and human body physiologic 
conditions. With taking required modifications on surface of these 
compounds, the conditions can be provided to bond the drug, protein 
and genetic materials (figure 3). Hence, targeted transfer of these 
compounds can be achieved with the effect of an external magnetic 
field [34-35]. 
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     Figure 3: schematic of shell/core structure of 
magnetic nanoparticles and decoration of their surface with 
different functional groups. 
These particles have been formed of magnetic iron oxide core and a 
coating of biocompatible materials such as polysaccharides, 
Dextran, Chitosan, Polyethylene glycol and polyvinyl alcohol. 
Functional groups in coating surface of nanoparticles have been used 
to link the ligands, molecular targeting, transferring nanoparticles to 
cancer cells and systematic drug delivery and other medical uses 
such as hyperthermia and magnetic resonance imaging [12]. 
3.2 Tumor imaging (diagnosis) 
Currently, magnetic nanoparticles are being used because of their 
capability in making contrast in MRI [36], which has lower toxicity 
and biologic adaptability [37]. Super paramagnetic nanoparticles (0-
10nm) can be used as contrast factor in MRI and bismuth 
nanoparticles can be used as contrast factor for CT. despite to their 
good absorption, they have nonspecific distribution and are fast in 
terms of pharmacokinetics. If the surface of the bismuth 
nanoparticles is covered by polymer, they can be protected from 
decomposition and the tissues can be protected against their toxic 
effect. The nanoparticles have shown good stability in high 
concentration, they can absorb high range of x-ray and their survival 
time in blood reaches to more than 2 hours. Therefore, the efficiency 
ratio of these particles to their non-toxicity is better than iodized 
materials in imaging [36]. Using quantum particles with infrared 
wavelength has been also reported for non-invasive tumor imaging 
in vivo [37].  
Gao et al [9] covered quantum particles using triplet copolymer 
amphiphilic (poly-methacrylate hydrophilic components and two 
poly-butyl acrylate hydrophobic parts and a polyethylene acrylate 
unit). The polymers protect nanoparticle against decomposition and 
as they contain polyethylene glycol molecules, they can improve 
biologic ability of quantum particles and their intercellular 
circulation. Conjugation of quantum particles with systematic 
antibodies against membrane specific genes of prostate can mark the 
human prostate cancer and can decrease the accumulation of 
quantum particles in liver and bone marrow. Moreover, 3 polymers 
with dimensions of 5.0µm of quantum particles with green, yellow 
and red colors can be observed simultaneously in 3 different parts. 
Despite to dextran conjugated with organic colors and influenced in 
tumor vessels and expose them to watch transparently; quantum 
particles mark vascular wall clearly, which can show expression of 
proteins containing green fluorescent color. Quantum particles link 
to endothelial sensitive tissue and target the lymph vessels around 
the tumor. Using quantum points with distribution range near the 
infrared have been recommended for tumor imaging. Determination 
of lymph nodes can be used to specify degree of melanoma and  
breast cancer. Conventional method is using blue color or injection 
of radioisotopes. Today, quantum nanoparticles have been also 
recommended to determine degree of cancer and for early diagnosis 
of cancer. The limitation of using quantum particles is because of 
their toxicity and this method is being developed with reduction of 
toxic effects of particles [38, 39]. 
3.3 Breast cancer treatment with magnetic hyperthermia 
processes 
Cancer treatment is one of the most important challenges for 
medical science and drug delivery. As the conventional treatments 
such as surgery, chemotherapy and radiotherapy are not so 
effective to treat some cancers such as glioblastoma; hyperthermia 
can be considered as a reliable approach for absolute treatment of 
these cancers. Cancer treatment by means of inductive irritation of 
super paramagnetic and biocompatible nanoparticles by means of 
alternative magnetic field of heating special tissues or organs to 
temperatures about 41-47°C for cancer treatment can be called 
hyperthermia (figure 4). 
Figure 4: a schematic of magnetic hyperthermia principles; the 
principles have been formed based on accumulation of magnetic 
nanoparticles in tumors compared to healthy tissues [12] 
Hyperthermia process with magnetic ferrofluid suggests possibility 
of positioning heat. This is because; cancer cells are sensitive to 
overheat of normal cells. Super paramagnetic nanoparticles can 
transmit the additional heat to target point through fluctuations of 
magnetic moments inside the nanoparticles. Therefore, solid cancer 
cells will be killed; although normal tissue cells remain under 
temperature below 41-47°C. Heating potential is highly depended on 
form and size of particles. Therefore, using single-organized 
magnetic particles in nano scale is prior to multi-organized particles 
in micro scale. This is because; nanoparticles can tolerate alternative 
magnetic field. The produced heat varies depending on frequency, 
magnetic field resonance and time of placement in magnetic field. 
Under this conditions, after placement of nanoparticles inside cells 
and placement of body under magnetic field; the particles produce 
positional and specific heat inside the cancer mass and accelerate 
destruction of tumor. Hence, hyperthermia can enhance treatment 
solid cancer [12]. 
3.4 Simultaneous imaging and treatment 
Nanoparticles conjugated with targeted antibodies are capable to 
be used simultaneously for diagnosis and treatment of cancer. 
Conjugation of target ligands can be done using Biotin and  
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Streptovidine. This method can be used to conjugate an ERBB2 
antibody to a metal nanoparticle to form a nanoshell [40]. The 
structure of this system is formed of a rounded nanoparticle in 
dielectric core and silica and surrounded by thin layer of gold. The 
nanoshell with a transmission spectrum close to infrared convert 
light to thermal energy and takes function for surgery of tumor or 
removal of tumor using thermal method. the nanoparticles making 
heat under the effect of near-IR radiation have effective efficiency 
to 1million times higher than colored molecules. The heat created 
by them is higher than the amount needed to create irreversible 
tissue damage and can cause cell death ultimately. Targeted 
nanoshells can be used for irreversible removal of breast tumor in 
vivo conditions. 
3.5 Breast cancer treatment 
Wide range studies have been taken to use nanoparticles to protect 
healthy tissues and to have killing effects on cancer cells. For 
example, Liposomal anthracycline can be used to treat all degrees 
of breast cancer [41]. However, using that is restricted because of 
toxic effects on heart. The compound, along with Trastuzumab as 
a monoclonal antibody against ERBB2, has better effect [42].   
It has been reported that liposome and Epiglottis liposome 
containing Doxorubicin can be used in treatment of metastatic 
breast cancer [43, 44]. Moreover, nanoparticles in core section 
containing paclitaxel and surrounded by albumin can be effective 
to carry hydrophobic molecules in breast cancer. Preclinical 
studies have revealed that paclitaxel contained in nanoparticles 
surrounded by albumin has better power of infiltration in tumor 
compared to conventional paclitaxel. Targeted delivery of 
tamoxifen can be taken in all stages of breast cancer. Tamoxifen 
is a Nonsteroidal and anti-estrogenic drug with high hydrophobic 
property [44]. Using nanoparticles with the drug can increase its 
influence to tumor. Moreover, its toxic effects on healthy tissues 
are low [45].   
4 Discussion 
As use of conventional diagnosis and imaging methods of tumor 
have some disadvantages and limitations; using nanotechnology like 
quantum nanoparticles, nanobodies and aptamers can be novel 
method for early diagnosis of cancer, especially breast cancer. In 
addition to diagnosis of cancer, aptamers can be effective for cancer 
treatment. Aptamer technology has been developed as a reliable and 
effective technology, many studies have been conducted on uses of 
aptamers, and the aptamers are being used in different dimensions as 
a diagnosis and treatment instrument and drug carrying systems. 
However, aptamers have not still found their position in field of 
medical diagnosis and treatment. 
Nanoparticles conjugated with antibodies can be used 
simultaneously to detect various molecular targets in small tumor 
pieces. Moreover, with regard to side effects of anticancer drugs, 
using safe drug delivery systems with biocompatibility like solid 
lipid nanoparticles and liposomes delivering drug to target tissue 
with high specificity is essential. The basis of this method is making 
enough amount of drug reach to tumor place for certain time and to 
reduce harmful effects of drug on other organs. Solid lipid 
nanoparticles can be considered as a complicated system with unique 
advantages and disadvantages, which can separate it from other 
colloid systems. Further studies are needed using magnetic-
resonance methods to clear drug delivery mechanism using the 
system. Limited information is available about toxicity aptamers. 
Therefore, to take aptamer therapy, it is necessary to know toxicity 
level. The main challenge in chemotherapy of cancer is unwanted 
effect and complications of drugs. The single dose or short term of 
using these drugs can cause serious risks for human health; although 
using biodegradable particles in nano scale for long term or  
treatment periods can cause unwanted harmful effects. Therefore, 
there are still some challenges and limitations to use nanoparticles in 
medication. It is hope that synthesis costs are reduced in near future 
and pharmacokinetic properties are increased to enhance 
productivity of nanoparticles and to overcome limitations of using 
them.  
Because of special magnetic properties, magnetic nanoparticles have 
gained clinical importance for diagnosis and treatment cancer. With 
analysis of various studies conducted in this field, it could be found 
that loading anti-cancer drugs on magnetic nanoparticles can play 
effective role in enhancement of drug mechanism and removal of 
cancer cells. The research results have shown that magnetic 
nanoparticles can improve performance of anticancer drugs 
(Doxorubicin and Sysplatin) in killing cancer cells through 
improvement of production of active oxygen species or other 
unknown mechanisms. In other words, magnetic nanoparticles can 
increase cell toxicity of anticancer drug and plays also key role in 
transfer of drug to tumor cells. Magnetic resonance imaging is a 
common method used for diagnosis of tumor and cancer. Using 
magnetic nanoparticles in this method can cause sensitiveness o this 
method for cancer diagnosis, so that cancer can be diagnosed in early 
stages and effective treatment measures can be taken for its certain 
treatment. In addition, special magnetic property of magnetic 
nanoparticles can be used in targeted drug delivery. The 
nanoparticles, especially iron oxide magnetic nanoparticles, can be 
used as nanocarrier to carry the drug because of capability of 
encapsulation of anticancer drugs and high biocompatibility and low 
biologic toxicity and high concentration capability in tumor. 
Through this, the side effects of the drug can be decreased 
significantly. According to the relevant studies and results obtained 
from this study, it could be mentioned that modern drug carrying and 
multifunctional systems can be designed in near future with high 
capability to carry drug to tumor point. In addition, they can be 
simultaneously used as contrast factor in magnetic resonance 
imaging and magnetic hyperthermia process for certain treatment of 
cancer.  
5 Conclusion 
In this study, in regard with nanoparticles, the advantages and uses 
of these particles for treatment and diagnosis of breast cancer are 
discussed. Nanoparticles can be used in medication in field of 
diagnosis and treatment of diseases, drug carrying and biologic 
imaging. Advancement of nanotechnology in oncology can 
provide special facilities to identify the various molecular targets 
simultaneously in small tumor samples to take treatment strategy. 
Using nanoparticles in the in vivo tumor imaging is being 
developed rapidly and targeting antigens relevant to cancer can be 
possible in future. In near future, nanotechnology science can 
make wonderful revolution not only in oncology, but also in all 
steps of medical sciences. 
Molecular targeting has been studied in field of development and 
advancement of tumor selecting factors used in magnetic 
resonance imaging. The factors promise more medical uses. 
Macromolecular ligands have gained high attractiveness to be 
used in targeting nanoparticles; although expensiveness of 
synthesis of these ligands and complicated nature of chemistry of 
bonding them to magnetic nanoparticles has made some problems 
and limitations in regard with using these factors in clinical and 
laboratory phases. Moreover, extension of cation capabilities to 
magnetic nanoparticles by peptides influencing in cell can shorten 
their residence in plasma and can remove them. Therefore, while 
using these materials to design platform and to make sure of 
selectiveness of tumor and for Pharmacokinetic preservation, it is 
required to make decisions to adjust cation activity. Any kind of 
proof on nanoparticles and clearing their functional mechanisms 
can be helpful to design novel anticancer nanocarriers. The nano-
carriers allow decreased use of cytotoxic drug with their  
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mechanism and allow also overcoming resistance of cancer cells 
to drug. 
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